| Chronic Kidney Disease |
1 |
1 |
| Renal Failure |
0 |
0.9 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Heart |
0 |
0.59 |
| Heart Failure (HF) |
0 |
0.47 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.44 |
| Kidney |
0 |
0.37 |
| Kidney, Ureter, and Bladder |
0 |
0.37 |
| Acute Kidney Injury |
0 |
0.36 |
| Cardiovascular Imaging |
0 |
0.33 |
| Type 2 Diabetes Mellitus |
0 |
0.32 |
| Renal Disease |
0 |
0.31 |
| Ejection Fraction |
0 |
0.98 |
| Washington |
0 |
0.15 |
| Adverse Effects |
0 |
0.07 |
| B-Type Natriuretic Peptide |
0 |
0.07 |
| Dorsum |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Match |
0 |
0.07 |
| Nail |
0 |
0.07 |
| Stress |
0 |
0.07 |
| Wound Management |
0 |
0.06 |
| Medical Life |
0 |
0.04 |
| Myocardial Infarction (MI) |
0 |
0.04 |
| Patient Safety |
0 |
0.04 |